Newly published research has demonstrated that a coxsackievirus B1 (CVB1) vaccine can protect against CVB1-induced type 1 diabetes in a mouse model: Paper: A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes Article: Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model Type 1 diabetes has been linked to coxsackievirus B1 (ref: 1), coxsackievirus B4 (refs: 1 2) and echovirus 4 (ref: 1). However, since correlation does not automatically imply causation, proving that these viruses actually cause diabetes is more tricky. This study adds to the evidence that these viruses may trigger type 1 diabetes, as they found that mice immunized with the coxsackievirus B1 vaccine were protected against both acute CVB1 infection and virus-induced diabetes in a mouse model of diabetes. This paves the way for clinical trials of a coxsackievirus B1 vaccine for humans, which would then provide the opportunity to test whether a CVB1 vaccine can prevent type 1 diabetes in humans. Ultimately, the development of coxsackievirus B vaccines will likely also prevent the bulk of cases of ME/CFS. ME/CFS tends to be linked to infection with CVB3 and CVB4 mainly, as well as other CVB and echovirus species (ref: 1). I started a thread about the dire need to develop coxsackievirus B vaccines in order to prevent ME/CFS here: Coxsackievirus B vaccine appears feasible, and may drastically reduce ME/CFS incidence in future With ME/CFS being once of the worst diseases you can have in terms of reduced quality of life, a preventative solution for this disease would be of the utmost importance.